Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease

Kidney International

Volumn 50, Issue 1, 1996, Pages 250-256

  Morocutti, Anna ^b   Earle, Kenneth A ^b   Sethi, Meera ^b   Piras, Giampiero ^b   Pal, Kalyani ^b   Richards, David ^b   Rodemann, Peter ^b   Viberti, Giancarlo ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL AGING; CELL METABOLISM; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PREMATURE AGING; PRIORITY JOURNAL; SENESCENCE; SKIN FIBROBLAST;

EID: 0029835531     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.309     Document Type: Article

References (57)

1. SEAQUIST ER, GOETZ FC, RICH S, BARBOSA J: Familial clustering of diabetic kidney disease. Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
2. BORCH-JOHNSEN K, NORGAARD K, HOMMEL E, MATHIESEN ER, JENSEN JS, DECKERT T, PARVING H-H: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
3. ANDERSEN AR, CHRISTIANSEN JS, ANDERSEN JK, KREINER S, DECKERT T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
4. KROLEWSKI AS, WARRAM JH, CHRIESTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785-794, 1985
5. KROLEWSKI AS, CANESSA M, WARRAM JH, LAFFEL LM, CHRISTLIEB AR, KNOWLER WC, RAND LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
6. VIBERTI GC, KEEN H, WISEMAN MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 295:515-17, 1987
7. EARLE KA, WALKER J, HILL C, VIBERTI GC: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992
8. BORCH-JOHNSEN K, ANDERSEN PK, DECKERT T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985
9. BORCH-JOHNSEN K, KREINER S: Proteinuria: Value as predictor of cardiovascular mortality in insulin-dependent diabetes. Br Med J 294:1651-1654, 1987
10. JENSEN T, BORCH-JOHNSEN K, KOFOED-ENEVOLDSEN A, DECKERT T: Coronary artery disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 30:144-148, 1987
11. ØSTERBY R, PARVING H-H, HOMMEL E, JØRGENSEN HE, LØKKEGAARD H: Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes 39:1057-1063, 1990
12. STEFFES MW, ØSTERBY R, CHAVERS B, MAUER SM: Mesangial expansion as a central mechanisms for loss of kidney function in diabetic patients. Diabetes 88:1077-1081, 1989
13. SAMPSOM MJ, CHAMBERS JB, SPRIGINGS DC, DRURY PL: Intraventricular septal hypertrophy in type 1 diabetic patients with microalhuminuria or early proteinuria. Diabetic Med 7:126-131, 1990
14. COOPER ME, ALLEN TJ, MCMILLAN P, CLARKE B, O'BRIEN RC, JEREMUS G, DOYLE AE: Effects of genetic hypertension on diabetic nephropathy in the rat. Functional and structural characteristics. Hypertension 6:1009-1016, 1988
15. DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
16. ZATZ R, MEYERE TW, RENNKE HG, BRENNER BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82:5963-5967, 1985
17. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
18. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42:1184-1190, 1992
19. + antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 33:371-377, 1990
20. + antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy. Clin Invest 71:114-125, 1993
21. + antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93:2750-2757, 1994
22. + exchanger gene family. J Membr Biol 135: 93-108, 1993
23. LURBE A, FIORETTO P, LAPOINTE M, MAUER M, BATTLE DC: Enhanced cell proliferation in cultured skin fibroblasts from patients with type 1 diabetes and nephropathy:role of sodium-hydrogen antiporter. (abstract) J Am Soc Nephrol 3:761, 1992
24. KEEN H, CHLOUVERAKIS C: An immunoassay method for urinary albumin at low concentration. Lancet ii:913-916, 1963
25. 53Cr-EDTA. Clin Sci 37:169-180, 1969
26. HARLEY CB: Ageing of cultured human skin fibroblasts. in Methods in Molecular Biology (vol 5), edited by POLLARD JW, WALKER JM, Clifton, The Human Press, 1990, pp 25-32
27. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
28. VINDELOV LL, CHRISTENSEN IJ: A review of techniques and results obtained in one laboratory by integrated system of methods designed for routine clinical flow cytometry DNA analysis. Cytometry 11:753-770, 1990
29. SHERWOOP SW, RUSH D, ELLSWORTH JL, SCHIMKE RT: Defining cellular senescence in IMR-90 cells: A How cytometric analysis. Proc Natl Acad Sci USA 85:9086-9090, 1988
30. VOGEL F, MOTULSKY AG: Human chromosome, in Human Genetics. Problems and Approaches, Berlin, Spring Verlag, 1979, pp 18-77
31. BAYREUTHER K, RODEMANN HP, HOMMEL R, DITTMANN K, ALBEIZ M, FRANCZ PI: Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci USA 85:5112-5116, 1988
32. GOLDSTEN S, MOERMAN EL, SOLDNER JS, GLEASON RE, BARNETT DM: Chronologic and physiologic age affect replicative lifespan of fibroblasts from diabetic, prediabetic. and normal donors. Science 199:781-782, 1978
33. LANE PH, STEFFES MW, FIORETTO P, MAUER SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667, 1993
34. OWENS GK, SCHWARTZ SM: Alteration in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy and hyperplasia. Cir Res 51:280-289, 1982
35. HAMADA M, NISHIO I, BABA A, FUKUDA K, TAKEDA J, URA M, HANO T, KUCHII M, MASUYAMA Y: Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 81:191-198, 1990
36. BARRETT TB, SAMSON P, OWENS GK, SCHWARTZ SM, BENDITT EP: Polyploid nuclei in human artery wall smooth muscle cells. Proc Natl Acad Sci USA 80:882-889, 1983
37. ANGELLO JC, PENDERGRASS WR, NORWOOD TH, PROTHERO J: Proliferative potential of human fibroblasts: An inverse dependence on cell size. J Cell Physiol 132:125-130, 1987
38. KOFOED-ENEVOLDSEN A, PETERSON JS, DECKERT T: Glucosaminyl N-deacetylase in cultured fibroblasts: Comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition. Diabetologia 36:536-540, 1993
39. BOUE A, BOUE J, CURE S, DELUCHAT C, PERAUDIN N: In vitro cultivation of cells from aneuploid human embryos, initiation of cell lines and longevity of the cultures. In Vitro 11:409-413, 1975
40. RODEMANN HP, BAYREUTHER K, FRANCZ PI, DITTMANN K, ALBIEZ M: Selective enrichment and biochemical characterization of human skin fibroblasts cell types in vitro. Exp Cell Res 180:84-93, 1989
41. RODEMANN HP, MULLER GA: Characterization of human renal fibroblasts in health and disease. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 6:684-686, 1991
42. TREVISAN R, YIP J, LI LK, VIBERTI GC: Enhanced collagen synthesis in cultured skin fibroblasts from insulin- dependent diabetic patients with nephropathy. (abstract) J Am Soc Nephrol 4:805, 1993
43. MARTIN GM, SPRAGUE CA, EPSTEIN CJ: Replication life-span of cultivated human cells: Effect of donor' s age, tissue, and genotype. Lab Invest 23:86-93, 1970
44. WANG DH, PREWITT RL: Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 15:68-77, 1990
45. FOGO A, ICHIKAWA I: Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 4:329-342, 1989
46. KING GL, JOHNSON S, WU G: Possible growth modulators involved in the pathogenesis of diabetic proliferative retinopathy, in Growth Factors in Health and Disease, edited by WESTERMARK B, BETSHOLTZ C, HOKFELT B, New York, Elsevier Company, 1990, pp 303-317
47. LORENZI M, NORDBERG JA, TOLEDO S: High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36:1261-1267, 1987
48. NAHMAN NS, LEONHARI KL, COSIO FG, HEBERT CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
49. KASHGARIAN M, STERZEI RB: The pathobiology of the mesangium. Kidney Int 41:524-529, 1992
50. TURNER JL, BIERMAN EL: Effects of glucose and sorbitol on proliferation of cultured human skin fibroblasts and arterial smooth muscle cells. Diabetes 27:583-588, 1978
51. ROY S, LORENZI M: The memory of abnormal gene expression induced by high glucose in human endothelial cells is gene-specific. (abstract) Diabetes 40(Suppl 1):9, 1991
52. GOLDSTEIN S: Lifespan of cultured cells in progeria. Lancet 1:424, 1969
53. FLEISCHMAJER R, NEDWICH S: Werner's syndrome. Am J Med 54: 111-119, 1973
54. GOLDSTEIN S, LITTLEFIELD JW, SOELDNER JS: Diabetes mellitus and ageing: Diminished plating efficiency of cultured human tibroblasts. Proc Natl Acad Sci USA 64:155-160, 1969
55. ROWE DW, STARMAN BJ, FUJIMOTO WJ, WILLIAMS RH: Abnormalities in proliferation and protein synthesis in skin fibroblasts cultures from patients with diabetes mellitus. Diabetes 26:284-290, 1977
56. VRACKO R, MCFARLAND BH: Lifespans of diabetic and nondiabetic fibroblasts in vitro. Results of replicative determinations. Exp Cell Res 129:345-350, 1980
57. ROSENBLOOM AL, ROSENBLOOM EK: Insulin-dependent childhood diabetes. Normal viability of cultured fibroblasts. Diabetes 27:338-341. 1978